Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.
about
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNSLithium: the pharmacodynamic actions of the amazing ionGlycogen synthase kinase 3: more than a namesakeZM336372 induces apoptosis associated with phosphorylation of GSK-3beta in pancreatic adenocarcinoma cell linesGSK-3: tricks of the trade for a multi-tasking kinaseHyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer diseaseGlycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeuticsGrowing the growth cone: remodeling the cytoskeleton to promote axon regenerationReview of pharmacological treatment in mood disorders and future directions for drug development.Lithium and autophagyA role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental healthMood stabilizers, glycogen synthase kinase-3beta and cell survivalCellular plasticity cascades in the pathophysiology and treatment of bipolar disorderLithium and bipolar mood disorder: the inositol-depletion hypothesis revisitedMolecular actions and clinical pharmacogenetics of lithium therapyAltered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatmentUnlocking mechanisms in interleukin-1β-induced changes in hippocampal neurogenesis--a role for GSK-3β and TLXNFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapyOncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas.Lithium and genetic inhibition of GSK3beta enhance the effect of methamphetamine on circadian rhythms in the mouseIs glycogen synthase kinase-3 a central modulator in mood regulation?Glycogen synthase kinase-3 is required for efficient Dictyostelium chemotaxis.Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons.Effects of GSK3 inhibitors on in vitro expansion and differentiation of human adipose-derived stem cells into adipocytesBeneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models.Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease.Stabilisation of β-catenin downstream of T cell receptor signalling.Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivoNeuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disordersLithium ameliorates autistic-like behaviors induced by neonatal isolation in rats.Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effectsPotential molecular and cellular mechanism of psychotropic drugsPharmacogenomics of mood stabilizers in the treatment of bipolar disorder.Lithium impacts on the amplitude and period of the molecular circadian clockwork.Influence of lithium cations on prolyl peptide bonds.GSK-3 activity is critical for the orientation of the cortical microtubules and the dorsoventral axis determination in zebrafish embryos.Does lithium prevent Alzheimer's disease?Co-prescription of medication for bipolar disorder and diabetes mellitus: a nationwide population-based study with focus on gender differences.Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in miceEndophenotypes in bipolar disorder.
P2860
Q21129334-5B8CED63-48C3-4575-BF00-C86C4CCB2D57Q22241779-2C0B2196-E2F8-4395-BB85-1039A78D0CB1Q24315635-99DF7DDB-F020-4AD0-A3EB-EBC8FE61DC5FQ24600930-507614AC-EE3C-41E5-83FA-EE2B5742F119Q24624069-E48A42DE-52EF-4659-A397-F2C90C7596A4Q24657243-0821CDDA-EAA0-488C-B47D-ECB0FD1EC431Q24685475-140AE2CC-5602-4203-8C05-B24579738971Q26829489-EDA85414-1F98-40A5-A65A-155979AD5D8DQ26853509-315161DB-D170-40F8-A6A7-A9F2201BE971Q26863513-2AB6D8D4-49C0-47B6-AAA5-497E93538881Q28118906-47AFFE60-E71B-4548-A821-B9E050CCDE3EQ28216404-6A53D96A-58E7-458D-9A3B-D9F8EC425653Q28251880-EA8124AE-2932-4361-B5E0-DD9A24DDEBE7Q28294604-0BBAE831-D32C-4650-853B-7D2B1FBB3CD5Q28307770-8073F254-4F0D-45E1-A76F-8FD70201AB6EQ28484464-3599767C-91BE-4824-80C8-8125E915CACCQ28571565-42502983-782E-40C1-A482-815BBA7FB92FQ28586033-8F209BA5-6D95-4E41-91B7-079AB69F3565Q30375911-594182F2-2841-455D-A810-87371D7DE8F9Q30435752-42DC8B40-E931-42BA-B940-B29855B158CEQ30475816-4E573D1D-2329-4362-B8B0-CE8EC529976AQ30495773-37040A5B-0290-4EF3-BD5D-5190D5430704Q33210968-9519F13B-ED2A-4E53-B88B-6228C893472EQ33319636-D6A76860-376F-4E5A-A83C-A7657767B1DCQ33566724-F5340753-B482-4168-AF28-4DC531257CDEQ33687072-62D40087-2F37-45A8-BEB4-82C68E7387D1Q33700471-B4ACE612-8479-48C0-98CA-507BFBE69DB7Q33771431-C1A0106F-FA75-4626-8037-BFAD1FC0C5FCQ33777958-34B3BAC3-5998-4269-B94F-F48C374D5C95Q33810377-7546B5C0-51D2-4983-AF57-F7E77A25E779Q33929918-04982DA0-7DCA-4CA6-B892-DEA95C6A1741Q34129880-021FD9B0-66A1-4557-B5FA-DD7F61FFADBFQ34146222-E14F1302-A783-4776-B5F5-0005F35E0908Q34200717-2500531F-1176-4611-B392-307D065F3788Q34241205-0625EFDF-4612-48D8-9BE0-8FB53109928CQ34264873-F9C75078-B613-4E46-8A9A-D64906279FB8Q34268138-631E4948-7951-441B-95A6-C798905BF4E1Q34491836-B106E61F-4B97-46F4-BE68-42EDC9947BBBQ34552307-9EBC03DD-1861-47EB-BDDF-B8B4B308B4DFQ34626051-ED440432-7E87-4F1E-B733-8B13B2921FE4
P2860
Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.
@ast
Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.
@en
type
label
Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.
@ast
Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.
@en
prefLabel
Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.
@ast
Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.
@en
P356
P1476
Lithium inhibits glycogen synthase kinase-3 by competition for magnesium
@en
P2093
P304
P356
10.1006/BBRC.2000.4169
P407
P577
2001-01-01T00:00:00Z